related documents
- A case series of Lynch syndrome-associated breast cancer. Conferences
- BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors. Conferences
- CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC). Conferences
- Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial Conferences
- Effects of a structured exercise program on physical activity and health-related fitness in colon cancer survivors: One year feasibility results from the NCIC CTG CO.21 (CHALLENGE) trial. Conferences
- Functional BRM promoter polymorphisms, pancreatic adenocarcinoma risk, and survival. Conferences
- Identifying variables that predict poor tumor biology and suboptimal outcomes in patients treated with cytoreduction and HIPEC. Conferences
- Impact of radiotherapy duration on outcomes in patients with esophageal cancer treated with definitive concurrent radiotherapy and chemotherapy on RTOG trials 8501 and 9405. Conferences
- PET-CT compared to no PET-CT in the management of potentially resectable colorectal cancer liver metastases: The costs implications of a randomized controlled trial Conferences
- Prognostic factors associated with long term survival in chemotherapy-treated advanced pancreatic cancer: A Canadian multicenter analysis. Conferences
- Safety and antitumor activity of selinexor (KPT-330), a first-in-class, oral XPO1 selective inhibitor of nuclear export: A phase I study expanded with colon cancer cohort. Conferences
- Simultaneous resection of colorectal cancer with synchronous liver metastases: A survey-based analysis. Conferences
- Simultaneous versus staged resection for synchronous colorectal cancer liver metastases: A population-based cohort study. Conferences
- Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study. Conferences